Sayad Pierre Sargis has filed 6 insider transactions across 1 company since November 2024.
Most recent transaction: a option exercise of 18456 shares of FENNEC PHARMACEUTICALS INC. ($FENC) on March 31, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Sayad Pierre Sargis | Chief Medical Officer | M | Common Shares | 18456 | $0.00 | 18,456.0000 | 28,577,000 | 9999.99% | 0.06% |
| March 31, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Sayad Pierre Sargis | Chief Medical Officer | M | Common shares | 171 | $0.00 | 18,627.0000 | 28,577,000 | 0.93% | 0.00% |
| March 28, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Sayad Pierre Sargis | Chief Medical Officer | M | Common shares | 2052 | $0.00 | 20,679.0000 | 28,577,000 | 11.02% | 0.01% |
| March 31, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Sayad Pierre Sargis | Chief Medical Officer | A | Stock Options | 120000 | $5.77 | 270,000.0000 | 28,577,000 | 80.00% | 0.42% |
| March 28, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Sayad Pierre Sargis | Chief Medical Officer | A | Restricted Share Unit | 10000 | $0.00 | 160,000.0000 | 27,294,000 | 6.67% | 0.04% |
| Nov. 13, 2024 | FENNEC PHARMACEUTICALS INC. | $FENC | Sayad Pierre Sargis | Chief Medical Officer | A | Stock Options | 150000 | $4.23 | 150,000.0000 | 27,371,000 | 9999.99% | 0.55% |